APA

Chapuis A. G., Lee S. M., Thompson J. A., Roberts I. M., Margolin K. A., Bhatia S., Sloan H. L., Lai I., Wagener F., Shibuya K., Cao J., Wolchok J. D., Greenberg P. D. & Yee C. (20170728). Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient. : The Journal of experimental medicine.

Chicago

Chapuis Aude G, Lee Sylvia M, Thompson John A, Roberts Ilana M, Margolin Kim A, Bhatia Shailender, Sloan Heather L, Lai Ivy, Wagener Felecia, Shibuya Kendall, Cao Jianhong, Wolchok Jedd D, Greenberg Philip D and Yee Cassian. 20170728. Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient. : The Journal of experimental medicine.

Harvard

Chapuis A. G., Lee S. M., Thompson J. A., Roberts I. M., Margolin K. A., Bhatia S., Sloan H. L., Lai I., Wagener F., Shibuya K., Cao J., Wolchok J. D., Greenberg P. D. and Yee C. (20170728). Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient. : The Journal of experimental medicine.

MLA

Chapuis Aude G, Lee Sylvia M, Thompson John A, Roberts Ilana M, Margolin Kim A, Bhatia Shailender, Sloan Heather L, Lai Ivy, Wagener Felecia, Shibuya Kendall, Cao Jianhong, Wolchok Jedd D, Greenberg Philip D and Yee Cassian. Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient. : The Journal of experimental medicine. 20170728.